BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9634648)

  • 21. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
    Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-course changes in pancreatic laboratory and morphologic parameters in two different acute pancreatitis models in rats.
    Takács T; Czakó L; Jármay K; Hegyi P; Pozsár J; Marosi E; Pap A; Lonovics J
    Acta Med Hung; 1994; 50(1-2):117-30. PubMed ID: 7543670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of graded doses of a cholecystokinin-like peptide with and without secretin on pancreatic growth and synthesis of RNA and polyamines in rats.
    Haarstad H; Petersen H
    Scand J Gastroenterol; 1989 Oct; 24(8):907-15. PubMed ID: 2480634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular Ca2+ response of pancreatic acini in cerulein-induced acute pancreatitis in rats.
    Okada N; Ohshio G; Tanaka T; Wang ZH; Doi R; Imamura M
    Hepatogastroenterology; 1998; 45(21):840-5. PubMed ID: 9684144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
    Bianchi BR; Miller TR; Witte DG; Lin CW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention by prostaglandins of caerulein-induced pancreatitis in rats.
    Robert A; Lum JT; Lancaster C; Olafsson AS; Kolbasa KP; Nezamis JE
    Lab Invest; 1989 May; 60(5):677-91. PubMed ID: 2469859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin.
    San Román JI; De Dios I; Manso MA; Calvo JJ; López MA
    Arch Int Physiol Biochim; 1990 Oct; 98(5):237-43. PubMed ID: 1708991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic secretory responses in L-arginine-induced pancreatitis: comparison of diabetic and nondiabetic rats.
    Hegyi P; Czako L; Takacs T; Szilvassy Z; Lonovics J
    Pancreas; 1999 Aug; 19(2):167-74. PubMed ID: 10438164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of gene expression of pancreatic secretory trypsin inhibitor-61 and -56 by bile and pancreatic juice in rats.
    Miyasaka K; Funakoshi A; Nakamura E; Teraoka H
    Pancreas; 1995 Oct; 11(3):246-55. PubMed ID: 8577678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous administration of estradiol and cholecystokinin alters exocrine pancreatic function in rats.
    Tangoku A; Doi R; Chowdhury P; Blevins GT; Pasley JN; Rayford PL
    Int J Pancreatol; 1993 Apr; 13(2):81-6. PubMed ID: 7684759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8.
    Karsenty L; Hajri A; Aprahamian M; Garaud JC; Doffoël M; Damgé C
    Pancreas; 1993 Mar; 8(2):204-11. PubMed ID: 8460096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreas growth, tyrosine kinase, PtdIns 3-kinase, and PLD involve high-affinity CCK-receptor occupation.
    Rivard N; Rydzewska G; Lods JS; Martinez J; Morisset J
    Am J Physiol; 1994 Jan; 266(1 Pt 1):G62-70. PubMed ID: 8304459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme changes in zymogen granules and in pancreatic secretion throughout long-term CCK treatment.
    de Dios I; Rodriguez A; Garcia-Montero A; Orfao A; Manso MA
    Peptides; 1997; 18(1):101-10. PubMed ID: 9114459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin is not a major regulator in the digestive system in the chicken.
    Satoh S; Furuse M; Choi YH; Okumura J
    Experientia; 1994 Sep; 50(9):812-4. PubMed ID: 7523179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of starvation on intestinal cholecystokinin-like activity and pancreatic growth.
    Brand SJ; Morgan RG
    J Physiol; 1981 Dec; 321():469-82. PubMed ID: 7338820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of CCK on CDE diet-induced acute pancreatitis in rats treated with hydrocortisone.
    Manso MA; Rebollo A; Pescador R; de Dios I
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jun; 111(2):257-63. PubMed ID: 8521247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats.
    Seo SW; Jung WS; Piao TG; Hong SH; Yun KJ; Park RK; Shin MK; Song HJ; Park SJ
    World J Gastroenterol; 2007 Apr; 13(16):2298-304. PubMed ID: 17511027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of CCK-8 on feeding, sham feeding, and exocrine pancreatic secretion in rats.
    Reidelberger RD; Solomon TE
    Am J Physiol; 1986 Jul; 251(1 Pt 2):R97-105. PubMed ID: 2425643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of continuous infusions of CCK-8 on food intake and body and pancreatic weights in rats.
    Lukaszewski L; Praissman M
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R17-22. PubMed ID: 3337268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.